Although it seems reasonable to suggest that most women experience significant changes in quality of life (QOL) during the menopausal period, few researchers have quantified these changes. A total of 1497 women, aged 40-54 years and living on the island of Kinmen, were recruited for this survey. However, 137 were eliminated leaving 1360 for analysis. Women who used hormonal therapy or who had undergone surgically induced menopause were excluded. The subjects with incomplete data or who exhibited mental retardation or severe psychiatric disease were also eliminated. Univariate analysis demonstrated that, in general, QOL scores were poorer for perimenopausal and postmenopausal status. Comparing pre-and postmenopausal women, significant statistical differences were demonstrated for role limitations due to physical and emotional problems, even after adjusting for age, education level, body mass index, menarche, and chronic illness. A strong association was demonstrated between menopausal symptoms and premenstrual syndrome (PMS). Women with menopausal symptoms and PMS had significantly lower scores on all SF-36 dimensions. The results of this study suggest that poorer health status is experienced by peri-and postmenopausal women compared to premenopausal women.
Introduction
Quality of life (QOL) is a multidimensional health concept, which represents mainly subjective symptoms that may influence the sense of wellbeing and day-to-day function. It includes several important domains, such as perceived well-being, role disability, and physical, psychological and social function. Women may experience significant QOL changes during menopause, and only a few researchers have quantified these changes [1] [2] [3] . Daly et al. [1] have even proposed that QOL is severely compromised by the presence of menopausal symptoms, indicating that the effects of these symptoms may have been underestimated.
The impact of menopause on QOL could be a consequence of biological changes, associated symptoms, and/or sociocultural factors. Several studies have demonstrated that hormone replacement therapy (HRT) improves QOL scores [4] [5] [6] [7] . Nevertheless, relatively few studies have explored the effects of menopause per se on QOL [2, 3] . Sociocultural factors may also affect the menopausal transition experience [8] . Studies of Asian samples [9, 10] indicate that the prevalence of vasomotor symptoms is markedly lower for these populations compared Western population. As menopausal experience differs for these populations compared to Western populations, cross-cultural studies may yield more information clarifying the relationship between menopause and QOL.
Implementation of a valid and accurate QOL instrument is also very important for producing more precise information and to enable better verification of statistical relationships. Although there is no gold standard for QOL measurement, a number of self-administered QOL instruments [11, 12] have been developed over the last 20 years and broadly applied to health-services research and clinical trials. Utilization of a well-known standard questionnaire for QOL evaluation will facilitate interpretation and comparison of results obtained from different studies throughout the world.
This research was part of a larger program investigating women's health and menopause. In this cross-sectional study of middle-aged women, we examined the relationship between QOL scores, menopause, and associated symptoms, using a validated instrument -the Medical Outcomes Study Short Form-36 (SF-36) [12, 13] .
Methods

Kinmen Women's-Health Investigation
Kinmen is a 176-km 2 island that is 248 km (154 miles) west of Taiwan and 41 km (25 miles) east of mainland China. It consists of four townships with a total population of 51,060 people (1998). The populace is served by two public hospitals and 31 physicians. The people of Kinmen are Han Chinese, most of whom are involved in farming activities or small business. There is no modern industry. Kinmen remained in close contact with China from the fourth century until the Japanese occupation in 1937. The government of the Republic of China reigned over the island again from 1945; however, it was under military control after the government moved to Taiwan in 1949. Kinmen became a popular tourist destination after martial law was lifted in 1993. Most of the people on Kinmen retain a traditional Chinese lifestyle, and living standards are similar to the rural areas of southern Taiwan.
There are four townships in Kinmen, with similar demographic compositions. Based on logistic convenience, Kin-Hu and Kin-Cheng were chosen for the study. From 1998 registration records, there were 2256 women aged 40-54 living in these two townships. This was the target population for the present study, and no sampling frame was used.
The Kinmen Women's-Health Investigation (KIWI) cohort was established in 1998. The study protocol was approved by the institutional review board of the Taipei Veterans General Hospital. Further details of the KIWI have been described elsewhere [13, 14] .
Medical Outcomes Study Short Form-36 (SF-36) Health Survey
The SF-36 questionnaire was originally developed for the Rand Corporation's Health Insurance Experiment [11] . Its reliability and validity have been tested in Taiwan [13] . It is a self-administered, 36-item questionnaire that measures healthrelated function in eight domains, including physical functioning, role limitations due to physical and emotional problems, vitality, bodily pain, social functioning, mental health, and general health perceptions. After summing the Likertscale items that make up SF-36, each scale was then standardized to range from 0 (lowest level of function) to 100 (highest level) [11] . As a general guide, Ware et al. [11] have suggested that a decrement of five points or more, for any of the SF-36 scales, is clinically relevant. Translation for a Taiwanese version of SF-36 was developed using standard methodology as detailed in the IQOLA Project [15] . The discriminative item validity was high for all subscales and Cronbach's a reliabilities were above 0.70 criterion with exception of two subscales [13] .
Other questionnaires
Additional study instruments included common sociodemographic questionnaires, a menopauserelated symptom checklist, the hospital anxiety and depression scale (HADS) [16, 17] and history of chronic illness. The height and weight of all the patients were measured, and the body mass index (BMI; calculated as weight (kg) divided by height (m) squared).
The menopause-related symptom checklist (symptoms experienced during the 2 weeks prior to the study) was a modification of the Kupperman index [18] . It included complaints of hot flushes, night sweating, dizzy spells, headaches, insomnia, fatigue, arthralgia, myalgia, backaches, vaginal dryness and frequent urination.
The participants were also asked about their menstrual and reproductive history including the PMS. ('Do you or did you suffer from PMS?') A number of questions investigating premenstrual symptoms experienced were also included to screen for PMS. PMS was defined based on the Tenth Revision of the International Classification of Diseases (ICD-10) as a history of at least one physical or mood symptom occurring in a cyclic fashion, that is, present during the last week before menses and absent in the week postmenses [19, 20] . These seven symptoms included minor psychological discomfort, bloating or weight gain, breast tenderness, muscular tension, aches and pains, poor concentration, and change in appetite.
The HADS was developed and validated using non-psychiatric patients [16, 17] . Items relating to both mood disorders and physical illnesses were omitted for the current study. The modified instrument consisted of 14 questions, seven for anxiety and seven for depression. Compared to general practitioners, superior diagnostic performance was demonstrated for detection of anxiety and depression. Scores range from 0 to 42. The Cronbach's a coefficient of Chinese HADS was 0.84 [17] . The optimal cut-off points of the HADS were a depression score of 6 and an anxiety score of 3. The sensitivity was 80% and specificity was 90% [21] .
The presence of chronic illness was assessed using 10 yes-or-no questions (for diabetes, hypertension, epilepsy, cancer, stroke, lung, liver, and renal disease, arthritis and other heart disease).
Definition of menopausal status
Menopausal status was classified as pre-, peri-or postmenopausal. The premenopausal period was defined by regular menstruation. A woman was considered perimenopausal if her menstrual cycles had been irregular or her last menstrual bleeding occurred more than three but less than or equal to 12 months prior to the study. Women who had not menstruated within the previous 12 months were categorized as postmenopausal. Those who used HRT or had surgically induced menopause were excluded from this study.
Data analysis
The SF-36 results were considered usable when respondents answered at least half of the items for each scale. When some (but fewer half) of the individual answers for a given scale were missing, the imputation method recommended by Ware et al. [11] was used to replace the missing items using the mean derived from other available scale items. For the present study, however, imputed scale scores were derived for only 0.7% of the respondents.
Kruskal-Wallis statistics and generalized linear models were used to compare QOL scores between menopausal status groups with and without adjustment for age, education, BMI, menarche, and presence of chronic illness.
Menopausal symptoms were analysed using two approaches. One involved the presence of individual symptoms, the other combined symptoms into four dummy categories: vasomotor (hot flushes, night sweats); psychosomatic (dizzy spells, headaches, insomnia, fatigue), physical (arthralgia, myalgia, backaches), and urovaginal (vaginal dryness, frequent urination). The v 2 test was used to assess the association between each pair of individual menopausal symptoms as well as the association between individual menopausal symptoms and menopausal status. The relationship between each menopausal-symptom category and QOL score was assessed using the Wilcoxon ranksum test. Further, to test the impact of menopausal symptoms on QOL score while controlling for menopausal status, the Wilcoxon rank-sum tests were performed separately for each menopausal status using the Bonferroni adjustment for the Type I-error rate.
The frequency distribution of menopausal symptoms was compared across PMS status groups using the v 2 test. The QOL scores were compared between women who experienced and did not experience PMS discomfort using the Wilcoxon rank-sum test. Furthermore, the same analysis was performed to test the influence of menopausal-symptom categories on QOL score while controlling for PMS. Additionally, the impact of PMS on menopausal symptoms was expressed using the odds ratio with 95% confidence interval.
All statistical tests were two sided. A p-value of 0.05 or less was considered statistically significant.
The Bonferroni adjustment was used for pairwise comparison.
Results
Characteristics of the study population
Of the 2256 targeted subjects, a total of 1497 (66%) participated in the study. The remaining 759 were not included for the following reasons: (1) not at home on each of the three house calls (n ¼ 634); (2) refused to participate (n ¼ 88); and (3) did not receive invitation due to mail-delivery failure (n ¼ 37). For the final analysis, 56 subjects with incomplete data were excluded, as were five who exhibited mental retardation or severe psychiatric illness, and 76 women who had undergone hysterectomy or HRT during the preceding 6 months. The final sample size was 1360. Table 1 presents the demographic and other characteristics for enrolled patients by menopausal status. Menopausal-status distribution was 734 (54%), 363 (27%), and 263 (19%) for pre-, periand postmenopause, respectively. Seventy-six percent of the postmenopausal women were within the first 3 years of menopause. The mean age was 45.4 years (SD: 4.0; range: 40-54) with a highly significant difference demonstrated for all pairwise menopausal-status comparisons (p < 0:0001). Similarly, significant BMI differences were determined comparing pre-and perimenopause, and pre-and postmenopause. No significant differences were demonstrated between age at menarche and menopausal status, however. Of the other demographic variables studied, a significant relationship with menopausal status was only demonstrated for education.
Impact of menopause on QOL score
The SF-36 scores for different menopausal status groups are presented in Table 2 . Except for social functioning, QOL scores were highest for premenopausal status and lowest for the postmenopausal women. Pairwise comparison indicated that the difference in QOL score was significant for physical functioning and role limitation due to physical problem comparing pre-and perimenopause (p ¼ 0:0001 and 0.005, respectively), and between pre-and postmenopause (p ¼ 0:002 and 0.0002, respectively). The biggest difference from pre-to postmenopause was demonstrated for role limitation due to physical problem (mean difference 8.8, CI [3.9, 13.6]), followed by role limitation due to emotional problem (mean difference 5.2, CI [0.5, 10.0]), and general health perception (mean difference 4.6, CI [1.7, 7.6]) in that postmenopausal women had lower scores than those who were premenopausal. Statistical significance was not demonstrated for any of these differences between premenopausal and perimenopausal status, how- ever. In addition, total HADS scores did not differ significantly between any of the three groups.
After controlling for age, education level, BMI, menarche, and their interactions, it was determined that the presence of chronic illness masked the influence of menopause on QOL score, accounting for the lack of significant difference in SF-36 scores between menopausal status groups. On the other hand, significant differences were demonstrated for role limitation due to physical and emotional problems, and general health perceptions scores comparing different menopausal status groups for women without chronic illness (p < 0:0001, p ¼ 0:02, and p ¼ 0:02, respectively). Further, ad hoc pairwise comparisons revealed differences for general health perception pre-and perimenopause, role limitation due to emotional problem pre-and postmenopause, and, role limitation due to physical problem pre-and postmenopause and peri-and postmenopause (p < 0:017).
Menopausal symptoms and SF-36 score
All menopausal symptoms were strongly associated with each other (except for the association between vaginal dryness and headaches (p ¼ 0:04)). Furthermore, women with vasomotor symptoms were more likely to have insomnia problems (64 vs. 47%, p < 0:001).
The prevalence of menopausal symptoms by menopausal status group is presented in Table 3 . Peri-and postmenopausal women had significantly higher frequencies of insomnia, arthralgia, vaginal dryness, hot flushes and night sweats compared with premenopausal women (p < 0:05; v 2 test). Except for frequent urination, which was most severe for perimenopausal status (p ¼ 0:004), postmenopausal women had higher frequencies for the above symptoms. The impact of menopausal-symptom category on QOL scores was also investigated. A breakdown of mean SF-36 scores for different menopausalsymptoms categories across the eight health-related SF-36 domains is presented in Table 4 . Significantly lower SF-36 scores were observed when comparing women with menopausal symptoms and those without (p < 0:0001). Further, this pattern was consistent across all eight of the healthrelated dimensions. Additional analysis revealed a similar pattern for SF-36 profiles with respect to the presence of menopausal symptoms in each category after controlling for menopausal status. Consistently lower SF-36 scores were determined for each menopausal status group where patients had all four categories of menopausal symptoms. Further, significantly lower SF-36 scores were noted for women who presented with vasomotor symptoms, despite controlling for the presence of insomnia symptoms (all p O 0.01, except role limitation due to emotional problem p=0.02).
Premenstrual syndrome
Overall, 44.4% of the enrolled women had PMS. A significantly higher frequency of menopausal symptoms (all p < 0:001, except vaginal dryness p ¼ 0:003) and lower SF-36 scores (all p O 0.0001) were observed when comparing women with PMS discomfort to those without.
The odds ratios for PMS relative to all 11 menopausal symptoms were between 1.5 and 2.4, with 95% confidence intervals excluding 1. This indicated that the likelihood of having menopausal symptoms was significantly higher for PMS sufferers.
Finally, the significantly lower SF-36 scores demonstrated for women who had symptoms in each of the four menopausal categories (compared with those who did not) were consistent with the scores for those with and without PMS (all p < 0:01, except for role limitation due to emotional problem vs. vasomotor symptoms without PMS, p ¼ 0:12).
Discussion
This study investigated a large community-based sample. Analysis of the results revealed that scores for both the physical and psychological components of QOL were worse for postmenopausal women than for premenopausal women. According to Ware et al. [11] a decrement of five points or more is clinically relevant. This criterion was fulfilled for both role limitation due to physical and emotional problems. Although a bigger impact on QOL was associated with presence of chronic illness, our results still support the proposition that QOL is lower for peri-and postmenopausal women in comparison to premenopausal women. The fact most of the postmenopausal women in our study were within 3 years of menopause, may explain why SF-36 scores did not differ significantly between peri-and postmenopausal women.
Menopausal transition was associated with several physical and psychological changes that may impact women's health outcomes. Several researchers have suggested that the menopausal transition leads to significant decreases in physical activity, energy expenditure, resting metabolic rate and fat-free mass [22, 23] . The findings of this study are consistent with those reported by Sowers et al. [24] , who demonstrated that even at the relatively young age of 40-55 years, approximately one-fifth of women self-reported limited physical function. Our study also revealed that the impact of menopause on physical-role function appears to be independent of age and BMI. The poorer physical-role function scores for perimenopausal and postmenopausal women may be associated with estrogen deficiency.
Compromised psychological well-being during the menopausal transition has long been noted. Nevertheless, the relationship is still controversial [25, 26] . Our study demonstrated that menstrual status is related to SF-36 role limitation due to emotional problem score but not HADS score. This discrepancy may be due to variations in sensitivity and the dimensions of the mental scales.
Of these so-called menopausal symptoms, only the frequencies of insomnia, arthralgia, and vasomotor and urogenital symptoms were significantly higher for the peri-and postmenopausal groups compared to the premenopausal group. Further, the magnitude of the impact of these menopausal symptoms on QOL score was striking. Those women with the menopausal symptoms listed above had marked impairment in all eight domains surveyed by the SF-36. Although the methodology of the study of Daly et al. [1] has been criticized [27] , our results support their finding that QOL may be compromised for women with menopausal symptoms. Our results are also in line with Ledesert et al. [2] who demonstrated that poorer reported QOL scores for postmenopausal women were explained by climacteric complaints. Nevertheless, we cannot rule out the possibility that poorer health status may predispose a woman to menopausal symptoms, rather than the contrasting notion that menopausal symptoms predispose females to poorer health status.
Disruption of sleep is a common problem, which has been associated with hot flushes [28] . It has been suggested that many of the mood changes associated with menopause may result from the sleep disruptions associated with hot flushes during the night [29, 30] . Our results confirm that women with vasomotor symptoms are more likely to have insomnia, however, the lower QOL score in this group cannot be explained by insomnia alone.
It is interesting to note that PMS had a significant impact on QOL score and menopausal symptoms for our subjects. Although retrospective diagnosis of PMS may be biased by recall error, our results are consistent with earlier findings of an association between vasomotor symptoms and previous PMS [31, 32] . The mechanisms of PMS are still controversial, however. It has been suggested that women with a history of PMS have increased sensitivity to hormonal changes [33] . There is also a socially mediated model, in which stressful life circumstances, menstrual socialization and depressed mood are associated with PMS [34] . The hypothalamic-pituitary-adrenal axis and autonomic nervous system also play important roles in PMS symptoms [35] . The association of PMS with higher frequency of menopausal symptoms and lower QOL scores may imply that women who are sensitive to hormonal changes are at increased risk for menopausal symptoms and reduced QOL during the menopausal transition. It is also possible that women prone to PMS usually have higher levels of life stress, causing the increased symptom frequency and reduced QOL.
The prevalence of vasomotor symptoms reported for Taiwanese is markedly lower than that reported in the western literature [14] . This finding is similar to other Asian studies [36] . Taiwanese women perceive menopause as a normal life process and are more positive about menopause than western women [37] . This is the first report of QOL for Asian women in midlife. It is not possible to be sure if the results can be extrapolated to other racial and ethnic groups, however. The positive aspects of menopausal transition for Taiwanese women notwithstanding, the impact on QOL cannot be overlooked for these traditional Chinese women.
In conclusion, it was determined in this crosssectional population-based study of rural Chinese women that QOL was poorer for naturally peri-and postmenopausal women within the first 3 years of menopause compared to premenopausal women, and that menopausal symptoms may have a significant impact on QOL. The validity of any extrapolation of our results to late-menopausal women is indeterminate, however, since most of our postmenopausal women were within 3 years of menopause and the incidence and severity of menopausal symptoms are greatest in the first 2 years of menopause after which they gradually decrease.
